PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ultimovacs

Ultimovacs Reports Data from the P-II (FOCUS) Study of UV1 Plus Keytruda to Treat Metastatic or Recurrent Head and Neck Cancer

Ultimovacs Reports Data from the P-II (FOCUS) Study of UV1 Plus Keytruda to Treat Metastatic or Recurrent Head and Neck Cancer

August 6, 2024

Ultimovacs Reports the Completion of Patient Enrolment in P-II Study (FOCUS) of UV1 for Head and Neck Cancer

Ultimovacs Reports the Completion of Patient Enrolment in P-II Study (FOCUS) of UV1 for Head and Neck Cancer

August 3, 2023

PharmaShots Weekly Snapshots (October 11 - 15, 2021)

PharmaShots Weekly Snapshots (October 11 - 15, 2021)

October 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us